Normosol-R

Product manufactured by Icu Medical Inc.

Application Nr Approved Date Route Status External Links
NDA017586 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Normosol-R Is Indicated For Replacement Of Acute Extracellular Fluid Volume Losses In Surgery, Trauma, Burns Or Shock. Normosol-R Also Can Be Used As An Adjunct To Restore A Decrease In Circulatory Volume In Patients With Moderate Blood Loss. Normosol-R Is Not Intended To Supplant Transfusion Of Whole Blood Or Packed Red Cells In The Presence Of Uncontrolled Hemorrhage Or Severe Reductions Of Red Cell Volume.

All Formulated Excipients (0 Total)

None

Comments